Diaceutics PLC

Symbol: DIUXF

PNK

1.3672

USD

Market price today

  • -124.8659

    P/E Ratio

  • 2.7906

    PEG Ratio

  • 123.70M

    MRK Cap

  • 0.00%

    DIV Yield

Diaceutics PLC (DIUXF) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.80%

Operating Profit Margin

-0.06%

Net Profit Margin

-0.03%

Return on Assets

-0.02%

Return on Equity

-0.02%

Return on Capital Employed

-0.04%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Mr. Peter Keeling
Full-time employees:151
City:Belfast
Address:Building Two
IPO:2020-05-29
CIK:

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

General Outlook

When we look at how much money they make before expenses, they keep 0.796% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.061%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.027%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.016% return, is a testament to Diaceutics PLC's adeptness in optimizing resource deployment. Diaceutics PLC's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.018%. Furthermore, the proficiency of Diaceutics PLC in capital utilization is underscored by a remarkable -0.038% return on capital employed.

Stock Prices

Diaceutics PLC's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.37, while its low point bottomed out at $1.37. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Diaceutics PLC's stock market.

Liquidity Ratios

Analyzing DIUXF liquidity ratios reveals its financial health of the firm. The current ratio of 798.66% gauges short-term asset coverage for liabilities. The quick ratio (774.52%) assesses immediate liquidity, while the cash ratio (510.71%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio798.66%
Quick Ratio774.52%
Cash Ratio510.71%

Profitability Ratios

DIUXF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -4.64% underscores its earnings before tax deductions. The effective tax rate stands at 3.21%, revealing its tax efficiency. The net income per EBT, 59.09%, and the EBT per EBIT, 76.19%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -6.09%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-4.64%
Effective Tax Rate3.21%
Net Income per EBT59.09%
EBT per EBIT76.19%
EBIT per Revenue-6.09%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 7.99, it details the span from stock purchase to revenue. The 8 days it takes to settle debts showcases its creditor relations. Meanwhile, a 5 cash conversion cycle and 290.84% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding775
Operating Cycle125.50
Days of Payables Outstanding19
Cash Conversion Cycle106
Receivables Turnover2.91
Payables Turnover19.06
Fixed Asset Turnover13.47
Asset Turnover0.58

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.04, and free cash flow per share, -0.03, depict cash generation on a per-share basis. The cash per share value, 0.21, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.12, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.04
Free Cash Flow per Share-0.03
Cash per Share0.21
Operating Cash Flow Sales Ratio0.12
Free Cash Flow to Operating Cash Flow Ratio-0.72
Cash Flow Coverage Ratio2.53
Short Term Coverage Ratio24.88
Capital Expenditure Coverage Ratio0.58
Dividend Paid and Capex Coverage Ratio0.58

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 2.73%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.03, we discern the balance between debt and equity financing. The long-term debt to capitalization, 2.68%, and total debt to capitalization, 2.98%, ratios shed light on its capital structure. An interest coverage of -17.04 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio2.73%
Debt Equity Ratio0.03
Long Term Debt to Capitalization2.68%
Total Debt to Capitalization2.98%
Interest Coverage-17.04
Cash Flow to Debt Ratio2.53
Company Equity Multiplier1.12

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.23, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.01, reflects the portion of profit attributed to each share. The book value per share, 0.51, represents the net asset value distributed per share, while the tangible book value per share, 0.32, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.23
Net Income Per Share0.01
Book Value Per Share0.51
Tangible Book Value Per Share0.32
Shareholders Equity Per Share0.51
Interest Debt Per Share0.02
Capex Per Share-0.06

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 59,660,685.815, captures the company's total value, considering both debt and equity. Income quality, 9.04, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 31.54%, indicates the value of non-physical assets, and capex to operating cash flow, -95.57%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value59,660,685.815
Income Quality9.04
Sales General and Administrative to Revenue0.83
Intangibles to Total Assets31.54%
Capex to Operating Cash Flow-95.57%
Capex to Revenue-24.97%
Capex to Depreciation-161.90%
Stock-Based Compensation to Revenue2.75%
Graham Number0.31
Return on Tangible Assets2.19%
Graham Net Net0.26
Working Capital27,144,000
Tangible Asset Value27,292,000
Net Current Asset Value25,154,000
Average Receivables10,192,000
Average Payables636,000
Average Inventory0.5
Days Sales Outstanding195
Days Payables Outstanding100
ROIC1.68%
ROE0.02%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.24, and the price to book ratio, 2.24, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.43, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -40.39, and price to operating cash flows, 28.88, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.24
Price to Book Ratio2.24
Price to Sales Ratio3.43
Price Cash Flow Ratio28.88
Price Earnings to Growth Ratio2.79
Enterprise Value Multiple43.65
Price Fair Value2.24
Price to Operating Cash Flow Ratio28.88
Price to Free Cash Flows Ratio-40.39
Price to Tangible Book Ratio1.84
Enterprise Value to Sales3.06
Enterprise Value Over EBITDA16.15
EV to Operating Cash Flow11.71
Earnings Yield0.93%
Free Cash Flow Yield0.29%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Diaceutics PLC (DIUXF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -124.866 in 2024.

What is the ticker symbol of Diaceutics PLC stock?

The ticker symbol of Diaceutics PLC stock is DIUXF.

What is company IPO date?

IPO date of Diaceutics PLC is 2020-05-29.

What is company current share price?

Current share price is 1.367 USD.

What is stock market cap today?

The market cap of stock today is 123699880.000.

What is PEG ratio in 2024?

The current 2.791 is 2.791 in 2024.

What is the number of employees in 2024?

In 2024 the company has 151.